Ciclesonide

Generic name
Ciclesonide
Brand name
ATC Code
R03BA08

Ciclesonide

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Asthma
  • Inhalation
    • 6 years up to 18 years
      [1] [2] [3]
      • 80 - 320 microg./day in 1 dose
      • Increase (double) the dose if asthma control is inadequate. Reduce dosage to the lowest effective dose when possible (see warning and precautions for asthma control roadmap)

        ≥ 6 years: aerosol + mouthpiece and holding chamber
        ≥ 7 years: aerosol + mouthpiece and holding chamber OR a breath-controlled aerosol

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

In long-term use in children, check the growth and if there is growth inhibition attempt to reduce the dose of inhalation corticosteroids.

[For stepwise approach in astma control: refer to national guideline or GINA]

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Glucocorticoids
R03BA01
R03BA02
R03BA05

References

  1. NVK, Astma bij Kinderen, www.nvk.nl, Okt 2013
  2. Covis Pharma Europe B.V., SmPC Alvesco (RVG 31631/31632/31633/32948) 16-09-2021, www.geneesmiddeleninformatiebank.nl
  3. Global Initiative for Asthma (GINA), Global strategy for Asthma management and prevention, 2021

Changes

Therapeutic Drug Monitoring


Overdose